AmacaThera Named Life Sciences Ontario Emerging Company of the Year
PR Newswire —
Recognition of AmacaThera's leadership and landmark agreement with Pacira BioSciences for its long‑acting, opioid‑sparing anesthetic in post‑operative pain management Progressing AMT-143 to Phase 2 clinical development in 2026 TORONTO, Feb. 11, 2026 /PRNewswire/ -- AmacaThera, a leading...